Bausch & Lomb Corp (STU:S2L)
€ 13.9 -0.2 (-1.42%) Market Cap: 4.97 Bil Enterprise Value: 8.90 Bil PE Ratio: 0 PB Ratio: 0.84 GF Score: 44/100

Bausch + Lomb Corp at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 07:15PM GMT
Release Date Price: €15.5 (+4.03%)
Robert Marcus JPMorgan Chase;Co.;Analyst

&-

Thanks, everyone. We're going to start our next session. Very happy to have the management team from Bausch & Lomb, Brent Saunders and Sam Eldessouky. We'll kick it off we're going to do a fireside chat for 40 minutes. If you have any questions, maybe we could quiet down if you don't mind if there are any questions in the audience. I'll pause and ask throughout just raise your hand and we'll call on you.

And so maybe we'll kick it off, Brent, you know, a year or so plus or minus in the role as the CEO., there's been a lot of activity on robust growth in the market and your business, you made a major acquisition. Maybe just sort of start off with the state of the union at the business and how things are going at Bausch & Lomb from your perspective.

Brent Saunders Bausch;Lomb Corporation;CEO

+-

Great. So first, thank you, guys for coming and Robbie, thanks for having us, and it's a pleasure to be here. So you're right, I started them not that I'm counting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot